COVID-19 in an Adult With Tricuspid Atresia S/P Fontan Palliation
- PMID: 32835267
- PMCID: PMC7236737
- DOI: 10.1016/j.jaccas.2020.05.013
COVID-19 in an Adult With Tricuspid Atresia S/P Fontan Palliation
Abstract
In December 2019, a pathogenic novel human coronavirus (HCoV), termed SARS-CoV-2, was recognized in Wuhan, China, causing significant morbidity and mortality. The illness caused by SARS-CoV-2 is labelled coronavirus disease-2019 (COVID-19) by the World Health Organization. We report the first case of COVID-19 in an adult congenital heart disease patient with single ventricle physiology S/P Fontan palliation. (Level of Difficulty: Advanced.).
Keywords: ALT, alanine aminotransferase; AST, aspartate transaminase; cyanotic heart disease; hypoxemia; tricuspid valve.
© 2020 The Authors.
Figures
References
-
- Sugiyama H., Yoo S.J., Williams W., Benson L.N. Characterization and treatment of systemic venous to pulmonary venous collaterals seen after the Fontan operation. Cardiol Young. 2003;13 42–30. - PubMed
-
- Srivastava D., Preminger T., Lock J.E. Hepatic venous blood and the development of pulmonary arteriovenous malformations in congenital heart disease. Circulation. 1995;92:1217–1222. - PubMed
-
- Dori Y., Keller M.S., Rychik J., Itkin M. Successful treatment of plastic bronchitis by selective lymphatic embolization in a Fontan patient. Pediatrics. 2014;134:e590–e595. - PubMed
-
- Williams D.B., Kiernan P.D., Metke M.P., Marsh H.M., Danielson G.K. Hemodynamic response to positive end-expiratory pressure following right atrium-pulmonary artery bypass (Fontan procedure) J Thorac Cardiovasc Surg. 1984;87:856–861. - PubMed
-
- Oldenburger N.J., Mank A., Etnel J., Takkenberg J.J., Helbing W.A. Drug therapy in the prevention of failure of the Fontan circulation: a systematic review. Cardiol Young. 2016;26:842–850. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous
